Zevra Therapeutics Announces Arimoclomol Research Featured
Interim data analysis of four-year, open-label extension from Phase 2/3 clinical trial suggests arimoclomol may reduce
Globe Newswire24-02-2023, 19:35
Preliminary Injunction Issued in favor of 2ONE® Nicotine Pouches Against Zone Pouches - Imperial are enjoined from engaging in any future sales of the [Zone] product bearing the Bullseye Mark or any colorable imitation or mark confusingly similar product 23-12-2024, 19:00